المؤلفون: Brinkmann, A.^Aff1, Röhr, A. C., Frey, O. R., Krüger, W. A., Brenner, T., Richter, D. C., Bodmann, K.‑F., Kresken, M.^{Aff6, Aff7}, Grabein, B.

المصدر: Der Anaesthesist: Zeitschrift für Anästhesie, Intensivmedizin, Notfall- und Katastrophenmedizin, Schmerztherapie. 67(12):936-949

المؤلفون: Wohlfarth, E, Kresken, M, Pfeifer, Y, Werner, G

المصدر: 63. Jahrestagung der Südwestdeutschen Gesellschaft für Urologie e.V.; 20230621-20230624; Reutlingen; DOCV10.7 /20230620/

مصطلحات الفهرس: ddc: 610, conferenceObject

URL: http://nbn-resolving.de/urn:nbn:de:0183-23swdgu0963
http://www.egms.de/en/meetings/swdgu2023/23swdgu096.shtml

المؤلفون: Olzowy, B., Kresken, M., Havel, M., Hafner, D., Körber-Irrgang, B., Working Party ‘Antimicrobial Resistance’ of the Paul-Ehrlich-Society for Chemotherapy

المصدر: European Journal of Clinical Microbiology & Infectious Diseases. September 2017 36(9):1685-1690

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Schleicher, X., Higgins, P.G., Wisplinghoff, H., Körber-Irrgang, B., Kresken, M., Seifert, H.

المصدر: In Clinical Microbiology and Infection August 2013 19(8):737-742

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Kresken, M, Pfeifer, Y, Werner, G

المصدر: GMS Infectious Diseases; VOL: 9; DOC08 /20211221/

مصطلحات الفهرس: Enterobacteriaceae, ESBL, CTX-M, Germany, ddc: 610, article

URL: http://nbn-resolving.de/urn:nbn:de:0183-id0000770
http://www.egms.de/en/journals/id/2021-9/id000077.shtml
Zusammenfassung der Merkmale des Arzneimittels Temopen 2g Pulver zur Herstellung einer Injektions-/Infusionslösung. August 2019.
Bouxom H, Fournier D, Bouiller K, Hocquet D, Bertrand X. Which non-carbapenem antibiotics are active against extended-spectrum beta-lactamase-producing Enterobacteriaceae? Int J Antimicrob Agents. 2018 Jul;52(1):100-3. DOI: 10.1016/j.ijantimicag.2018.03.014
EUCAST. Temocillin. Rationale for the EUCAST clinical breakpoints. Version 1.0. 2019 Mar 27. Available from: https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Rationale_documents/Temocillin_rationale_document_v1.0_20200327.pdf
European Centre for Disease Prevention and Control. Antimicrobial resistance in the EU/EEA (EARS-Net) - Annual Epidemiological Report 2019. Stockholm: ECDC; 2020 Nov 18. Available from: https://www.ecdc.europa.eu/en/publications-data/surveillance-antimicrobial-resistance-europe-2019
European Centre for Disease Prevention and Control. Surveillance Atlas of Infectious Diseases. ECDC, Stockholm, Sweden. [data retrieved 2021 Mar 8]. Available from: https://www.ecdc.europa.eu/en/surveillance-atlas-infectious-diseases
Gutiérrez-Gutiérrez B, Rodríguez-Baño J. Current options for the treatment of infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in different groups of patients. Clin Microbiol Infect. 2019 Aug;25(8):932-42. DOI: 10.1016/j.cmi.2019.03.030
International Organization for Standardization. ISO 20776-1:2006. Clinical laboratory testing and in vitro diagnostic test systems - susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices - part 1. Reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases. Geneva; 2006.
Jacoby GA. AmpC beta-lactamases. Clin Microbiol Rev. 2009 Jan;22(1):161-82. DOI: 10.1128/CMR.00036-08
Klein EY, Van Boeckel TP, Martinez EM, Pant S, Gandra S, Levin SA, Goossens H, Laxminarayan R. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci USA. 2018 Apr;115(15):E3463-70. DOI: 10.1073/pnas.1717295115
Kresken M, Pfeifer Y, Werner G. Temocillin susceptibility in Enterobacterales with an ESBL/AmpC phenotype. Int J Antimicrob Agents. 2021 Jan;57(1):106223. DOI: 10.1016/j.ijantimicag.2020.106223
Kresken M, Pfeifer Y, Werner G. Data from: Comparative in vitro activity of piperacillin-tazobactam and temocillin against third-generation cephalosporin-resistant, carbapenem-susceptible Escherichia coli and Klebsiella pneumoniae. Dryad Digital Repository. 2021. DOI: 10.5061/dryad.931zcrjkc
Kuch A, Zieniuk B, Zabicka D, Van de Velde S, Literacka E, Skoczynska A, Hryniewicz W. Activity of temocillin against ESBL-, AmpC-, and/or KPC-producing Enterobacterales isolated in Poland. Eur J Clin Microbiol Infect Dis. 2020 Jun;39(6):1185-91. DOI: 10.1007/s10096-020-03844-5
Laterre PF, Wittebole X, Van de Velde S, Muller AE, Mouton JW, Carryn S, Tulkens PM, Dugernier T. Temocillin (6 g daily) in critically ill patients: continuous infusion versus three times daily administration. J Antimicrob Chemother. 2015 Mar;70(3):891-8. DOI: 10.1093/jac/dku465
Le Scouarnec M, Guérin F, Zouari A, Farfour E, Walewski V, Dortet L, Fangous MS, Degand N, Fihman V, Janvier F, Bille E, Le Brun C, Poisson A, Gallois E, Michaud A, Piau C, Birer A, Cattoir V. New insights on molecular mechanisms of temocillin resistance in Escherichia coli. 31st European Congress of Clinical Microbiology and Infectious Diseases (ECCMID); 9-12 July 2021. 2135. Available from: https://eacademy.escmid.org/escmid/2021/eccmid-2021/328557/vincent.cattoir.new.insights.on.molecular.mechanisms.of.temocilllin.resistance.html
Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M, Cornaglia G, Garau J, Gniadkowski M, Hayden MK, Kumarasamy K, Livermore DM, Maya JJ, Nordmann P, Patel JB, Paterson DL, Pitout J, Villegas MV, Wang H, Woodford N, Quinn JP. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013 Sep;13(9):785-96. DOI: 10.1016/S1473-3099(13)70190-7
Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev. 2005 Oct;18(4):657-86. DOI: 10.1128/CMR.18.4.657-686.2005
Rodriguez-Villalobos H, Bogaerts P, Berhin C, Bauraing C, Deplano A, Montesinos I, de Mendonça R, Jans B, Glupczynski Y. Trends in production of extended-spectrum beta-lactamases among Enterobacteriaceae of clinical interest: results of a nationwide survey in Belgian hospitals. J Antimicrob Chemother. 2011 Jan;66(1):37-47. DOI: 10.1093/jac/dkq388
Rodríguez-Baño J, Gutiérrez-Gutiérrez B, Machuca I, Pascual A. Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae. Clin Microbiol Rev. 2018 Feb;31(2):e00079-17. DOI: 10.1128/CMR.00079-17
The European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters, Version 11.0. 2021 Jan. Available from: https://eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_11.0_Breakpoint_Tables.pdf
Working Party Antimicrobial Resistance of the Paul-Ehrlich-Society for Chemotherapy. Interactive database. [data retrieved 2021 Mar 8]. Available from: https://www.p-e-g.org/resistenz/database
http://dx.doi.org/https://doi.org/10.5061/dryad.931zcrjkc

المؤلفون: Schweickert, B., Kern, W.V., de With, K., Meyer, E., Berner, R., Kresken, M., Fellhauer, M., Abele-Horn, M., Eckmanns, T.

المصدر: Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. July 2013 56(7):903-912

المؤلفون: Kresken, M., Becker, K., Seifert, H., Leitner, E., Körber-Irrgang, B., von Eiff, C., Löschmann, P.-A., Study Group

المصدر: European Journal of Clinical Microbiology & Infectious Diseases. September 2011 30(9):1095-1103

المؤلفون: Kresken, M., Leitner, E., Seifert, H., Peters, G., von Eiff, C.

المصدر: European Journal of Clinical Microbiology & Infectious Diseases. August 2009 28(8):1007-1011